These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16536999)

  • 41. [The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
    Tang LL; Ma J; Chen Y; Zong JF; Sun Y; Wang Y; Wu HB; Cui NJ
    Ai Zheng; 2007 Jul; 26(7):737-41. PubMed ID: 17626750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
    Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance.
    Ichise M; Chung DG; Wang P; Wortzman G; Gray BG; Franks W
    J Nucl Med; 1994 Feb; 35(2):217-26. PubMed ID: 8294988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging tumor hypoxia and tumor perfusion.
    Groshar D; McEwan AJ; Parliament MB; Urtasun RC; Golberg LE; Hoskinson M; Mercer JR; Mannan RH; Wiebe LI; Chapman JD
    J Nucl Med; 1993 Jun; 34(6):885-8. PubMed ID: 8389842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy.
    Ma X; Lu JJ; Loh KS; Shakespeare TP; Thiagarajan A; Goh BC; Tan KS
    Laryngoscope; 2006 Dec; 116(12):2162-5. PubMed ID: 17146390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
    Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
    J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of ischemic myocardium with a new hypoxic tissue targeting tracer 99Tc(m)-HL91.
    Lü J; Liu G; Fang Y; Wu H
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):281-3, 291. PubMed ID: 16961269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation.
    Kinuya S; Yokoyama K; Konishi S; Li XF; Watanabe N; Shuke N; Aburano T; Takayama T; Michigishi T; Tonami N
    Ann Nucl Med; 2000 Apr; 14(2):139-41. PubMed ID: 10830534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions.
    Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C
    Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
    Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of recurrent nasopharyngeal carcinomas with thallium-201 single-photon emission computed tomography in patients with indeterminate magnetic resonance imaging findings after radiotherapy.
    Tai CJ; Liang JA; Yang SN; Tsai MH; Lin CC; Kao CH
    Head Neck; 2003 Mar; 25(3):227-31. PubMed ID: 12599290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Investigation of the site of origin to develop micro-focal nasopharyngeal carcinoma].
    Kuang GQ; Mo LG; Yang RN
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):505-6. PubMed ID: 16188155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 11C-acetate clearance in nasopharyngeal carcinoma.
    Yeh SH; Liu RS; Wu LC; Yen SH; Chang CW; Chen KY
    Nucl Med Commun; 1999 Feb; 20(2):131-4. PubMed ID: 10088161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Positive rate of radionuclide bone imaging and treatment in no ostalgia patients with new nasopharyngeal carcinoma].
    Mo HY; Zhang F; Hong MH; Fan W; Zheng L; Min HQ
    Ai Zheng; 2002 Mar; 21(3):323-5. PubMed ID: 12452005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
    Pan WL; Wong JH; Fang EF; Chan YS; Ng TB; Cheung RC
    Biochem Pharmacol; 2014 Jun; 89(3):329-39. PubMed ID: 24637239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.